Cargando…
Analgesic properties of a dexmedetomidine infusion after uvulopalatopharyngoplasty in patients with obstructive sleep apnea
BACKGROUND: Dexmedetomidine is an alpha(2) -adrenergic agonist with sedative and analgesic properties. This study aimed to investigate if the use of a continuous dexmedetomidine infusion with i.v. morphine patient-controlled analgesia (PCA) could improve postoperative analgesia while reducing opioid...
Autores principales: | Abdelmageed, Waleed M., Elquesny, Kaled M., Shabana, Ramadn I., Abushama, Hossam M., Nassar, Ahmad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139306/ https://www.ncbi.nlm.nih.gov/pubmed/21804794 http://dx.doi.org/10.4103/1658-354X.82782 |
Ejemplares similares
-
Retraction: Analgesic properties of dexmedetomidine infusion after uvulopalatopharyngoplasty in patients with obstructive sleep apnea
Publicado: (2020) -
Clinical Predictors for Successful Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea
por: Yousuf, Aamir, et al.
Publicado: (2013) -
Effect of Isolated Uvulopalatopharyngoplasty on Subjective Obstructive Sleep Apnea Symptoms
por: Choi, Ji Ho, et al.
Publicado: (2013) -
Mechanisms Underlying Improvement in Obstructive Sleep Apnea Syndrome by Uvulopalatopharyngoplasty
por: Yamamoto, Takahisa, et al.
Publicado: (2017) -
Polysomnography and Nocturia Evaluations after Uvulopalatopharyngoplasty for Obstructive Sleep Apnea Syndrome
por: Tsou, Yung-An, et al.
Publicado: (2020)